0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inhaled Nitric Oxide Market Research Report 2026
Published Date: 2026-01-16
|
Report Code: QYRE-Auto-35M8798
Home | Market Reports | Business & Industrial| Energy & Utilities| Oil & Gas
Global Inhaled Nitric Oxide Market Outlook 2022
BUY CHAPTERS

Global Inhaled Nitric Oxide Market Research Report 2026

Code: QYRE-Auto-35M8798
Report
2026-01-16
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Inhaled Nitric Oxide Market Size

The global Inhaled Nitric Oxide market was valued at US$ 659 million in 2025 and is anticipated to reach US$ 992 million by 2032, at a CAGR of 6.1% from 2026 to 2032.

Inhaled Nitric Oxide Market

Inhaled Nitric Oxide Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Inhaled Nitric Oxide competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Inhaled Nitric Oxide (iNO) is a gas therapy widely used in the treatment of respiratory diseases, particularly neonatal respiratory distress syndrome (NRDS) and acute respiratory distress syndrome (ARDS) in adults. As a vasodilator, nitric oxide works by dilating the small blood vessels in the lungs, improving the matching of ventilation and blood flow in the alveoli, which in turn enhances oxygenation and reduces pulmonary arterial pressure. The therapeutic mechanism of inhaled nitric oxide primarily relies on its direct action on the smooth muscle of the pulmonary vessels, promoting the release of nitric oxide and thereby improving the vessel's ability to dilate, effectively improving the patient's oxygenation and respiratory function.
Currently, the products of inhaled nitric oxide mainly consist of gas formulations and related delivery devices, such as inhalers and gas concentration regulation systems. These products have been approved in many countries and regions and are widely used in neonatal intensive care units (NICU), adult ICUs, and emergency departments. With the increasing clinical demand, the application of inhaled nitric oxide in various respiratory diseases has a promising future, especially in promoting recovery in patients with acute lung injury.
The inhaled nitric oxide market continues to grow globally, driven by several factors. Firstly, with the rising incidence of respiratory diseases, particularly in neonatal and elderly populations, the demand for inhaled nitric oxide is increasing. Inhaled nitric oxide can significantly improve clinical symptoms in patients with acute respiratory distress syndrome and other pulmonary diseases, shorten hospital stays, and improve quality of life, thereby generating strong market demand.
Secondly, technological advancements are driving market growth. New delivery devices continue to emerge, enhancing the therapeutic efficacy and safety of inhaled nitric oxide. For example, convenient gas concentration regulation systems allow patients to precisely control their inhaled dosage, thus reducing side effects. Additionally, clinical research has shown that inhaled nitric oxide is effective not only in neonates but also in adult critically ill patients, demonstrating promising therapeutic potential.
However, the market also faces some challenges and risks. Firstly, the high cost of inhaled nitric oxide remains a significant barrier to widespread adoption, particularly in developing countries, where the expensive treatment cost limits its accessibility. Secondly, while inhaled nitric oxide has been widely used in treating specific diseases, its efficacy and safety still require further clinical data, especially in atypical cases.
The market concentration is relatively high, dominated by a few leading pharmaceutical and medical device companies, which have extensive experience in product development, marketing, and clinical trials. In the future, as technology advances and treatment methods become more widespread, market concentration may decrease. The downstream demand trend reflects a growing need for more personalized and efficient treatment methods, driving the development of customized devices and new drugs.
This report delivers a comprehensive overview of the global Inhaled Nitric Oxide market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Inhaled Nitric Oxide. The Inhaled Nitric Oxide market size, estimates, and forecasts are provided in terms of sales volume (M L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Inhaled Nitric Oxide market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Inhaled Nitric Oxide manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Inhaled Nitric Oxide Market Report

Report Metric Details
Report Name Inhaled Nitric Oxide Market
Accounted market size in 2025 US$ 659 million
Forecasted market size in 2032 US$ 992 million
CAGR 6.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • High Purity iNO
  • Standard Purity iNO
by Application
  • Infants PPHN
  • ARDS
  • Other Diseases
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mallinckrodt (INOmax), Linde (Noxivent), Air Liquide (KINOX)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Inhaled Nitric Oxide manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Inhaled Nitric Oxide sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Inhaled Nitric Oxide Market growing?

Ans: The Inhaled Nitric Oxide Market witnessing a CAGR of 6.1% during the forecast period 2026-2032.

What is the Inhaled Nitric Oxide Market size in 2032?

Ans: The Inhaled Nitric Oxide Market size in 2032 will be US$ 992 million.

Who are the main players in the Inhaled Nitric Oxide Market report?

Ans: The main players in the Inhaled Nitric Oxide Market are Mallinckrodt (INOmax), Linde (Noxivent), Air Liquide (KINOX)

What are the Application segmentation covered in the Inhaled Nitric Oxide Market report?

Ans: The Applications covered in the Inhaled Nitric Oxide Market report are Infants PPHN, ARDS, Other Diseases

What are the Type segmentation covered in the Inhaled Nitric Oxide Market report?

Ans: The Types covered in the Inhaled Nitric Oxide Market report are High Purity iNO, Standard Purity iNO

1 Inhaled Nitric Oxide Market Overview
1.1 Product Definition
1.2 Inhaled Nitric Oxide by Type
1.2.1 Global Inhaled Nitric Oxide Market Value by Type: 2025 vs 2032
1.2.2 High Purity iNO
1.2.3 Standard Purity iNO
1.3 Inhaled Nitric Oxide by Application
1.3.1 Global Inhaled Nitric Oxide Market Value by Application: 2025 vs 2032
1.3.2 Infants PPHN
1.3.3 ARDS
1.3.4 Other Diseases
1.4 Global Inhaled Nitric Oxide Market Size Estimates and Forecasts
1.4.1 Global Inhaled Nitric Oxide Revenue 2021–2032
1.4.2 Global Inhaled Nitric Oxide Sales 2021–2032
1.4.3 Global Inhaled Nitric Oxide Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Inhaled Nitric Oxide Market Competition by Manufacturers
2.1 Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2021–2026)
2.2 Global Inhaled Nitric Oxide Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Inhaled Nitric Oxide Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Inhaled Nitric Oxide, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Inhaled Nitric Oxide, Product Types and Applications
2.7 Global Key Manufacturers of Inhaled Nitric Oxide, Date of Entry into the Industry
2.8 Global Inhaled Nitric Oxide Market Competitive Situation and Trends
2.8.1 Global Inhaled Nitric Oxide Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Inhaled Nitric Oxide Players Market Share by Revenue
2.8.3 Global Inhaled Nitric Oxide Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhaled Nitric Oxide Market Scenario by Region
3.1 Global Inhaled Nitric Oxide Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Inhaled Nitric Oxide Sales by Region: 2021–2032
3.2.1 Global Inhaled Nitric Oxide Sales by Region: 2021–2026
3.2.2 Global Inhaled Nitric Oxide Sales by Region: 2027–2032
3.3 Global Inhaled Nitric Oxide Revenue by Region: 2021–2032
3.3.1 Global Inhaled Nitric Oxide Revenue by Region: 2021–2026
3.3.2 Global Inhaled Nitric Oxide Revenue by Region: 2027–2032
3.4 North America Inhaled Nitric Oxide Market Facts & Figures by Country
3.4.1 North America Inhaled Nitric Oxide Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Inhaled Nitric Oxide Sales by Country (2021–2032)
3.4.3 North America Inhaled Nitric Oxide Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inhaled Nitric Oxide Market Facts & Figures by Country
3.5.1 Europe Inhaled Nitric Oxide Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Inhaled Nitric Oxide Sales by Country (2021–2032)
3.5.3 Europe Inhaled Nitric Oxide Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhaled Nitric Oxide Market Facts & Figures by Region
3.6.1 Asia Pacific Inhaled Nitric Oxide Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Inhaled Nitric Oxide Sales by Region (2021–2032)
3.6.3 Asia Pacific Inhaled Nitric Oxide Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inhaled Nitric Oxide Market Facts & Figures by Country
3.7.1 Latin America Inhaled Nitric Oxide Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Inhaled Nitric Oxide Sales by Country (2021–2032)
3.7.3 Latin America Inhaled Nitric Oxide Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhaled Nitric Oxide Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhaled Nitric Oxide Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Inhaled Nitric Oxide Sales by Country (2021–2032)
3.8.3 Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inhaled Nitric Oxide Sales by Type (2021–2032)
4.1.1 Global Inhaled Nitric Oxide Sales by Type (2021–2026)
4.1.2 Global Inhaled Nitric Oxide Sales by Type (2027–2032)
4.1.3 Global Inhaled Nitric Oxide Sales Market Share by Type (2021–2032)
4.2 Global Inhaled Nitric Oxide Revenue by Type (2021–2032)
4.2.1 Global Inhaled Nitric Oxide Revenue by Type (2021–2026)
4.2.2 Global Inhaled Nitric Oxide Revenue by Type (2027–2032)
4.2.3 Global Inhaled Nitric Oxide Revenue Market Share by Type (2021–2032)
4.3 Global Inhaled Nitric Oxide Price by Type (2021–2032)
5 Segment by Application
5.1 Global Inhaled Nitric Oxide Sales by Application (2021–2032)
5.1.1 Global Inhaled Nitric Oxide Sales by Application (2021–2026)
5.1.2 Global Inhaled Nitric Oxide Sales by Application (2027–2032)
5.1.3 Global Inhaled Nitric Oxide Sales Market Share by Application (2021–2032)
5.2 Global Inhaled Nitric Oxide Revenue by Application (2021–2032)
5.2.1 Global Inhaled Nitric Oxide Revenue by Application (2021–2026)
5.2.2 Global Inhaled Nitric Oxide Revenue by Application (2027–2032)
5.2.3 Global Inhaled Nitric Oxide Revenue Market Share by Application (2021–2032)
5.3 Global Inhaled Nitric Oxide Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Mallinckrodt (INOmax)
6.1.1 Mallinckrodt (INOmax) Company Information
6.1.2 Mallinckrodt (INOmax) Description and Business Overview
6.1.3 Mallinckrodt (INOmax) Inhaled Nitric Oxide Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Mallinckrodt (INOmax) Inhaled Nitric Oxide Product Portfolio
6.1.5 Mallinckrodt (INOmax) Recent Developments/Updates
6.2 Linde (Noxivent)
6.2.1 Linde (Noxivent) Company Information
6.2.2 Linde (Noxivent) Description and Business Overview
6.2.3 Linde (Noxivent) Inhaled Nitric Oxide Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Linde (Noxivent) Inhaled Nitric Oxide Product Portfolio
6.2.5 Linde (Noxivent) Recent Developments/Updates
6.3 Air Liquide (KINOX)
6.3.1 Air Liquide (KINOX) Company Information
6.3.2 Air Liquide (KINOX) Description and Business Overview
6.3.3 Air Liquide (KINOX) Inhaled Nitric Oxide Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Air Liquide (KINOX) Inhaled Nitric Oxide Product Portfolio
6.3.5 Air Liquide (KINOX) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhaled Nitric Oxide Industry Chain Analysis
7.2 Inhaled Nitric Oxide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhaled Nitric Oxide Production Mode & Process Analysis
7.4 Inhaled Nitric Oxide Sales and Marketing
7.4.1 Inhaled Nitric Oxide Sales Channels
7.4.2 Inhaled Nitric Oxide Distributors
7.5 Inhaled Nitric Oxide Customer Analysis
8 Inhaled Nitric Oxide Market Dynamics
8.1 Inhaled Nitric Oxide Industry Trends
8.2 Inhaled Nitric Oxide Market Drivers
8.3 Inhaled Nitric Oxide Market Challenges
8.4 Inhaled Nitric Oxide Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Inhaled Nitric Oxide Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Inhaled Nitric Oxide Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Inhaled Nitric Oxide Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Inhaled Nitric Oxide Sales (M L) of Key Manufacturers (2021–2026)
 Table 5. Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Inhaled Nitric Oxide Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Inhaled Nitric Oxide Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Inhaled Nitric Oxide Average Price (US$/L) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Inhaled Nitric Oxide, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Inhaled Nitric Oxide, Product Types and Applications
 Table 12. Global Key Manufacturers of Inhaled Nitric Oxide, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inhaled Nitric Oxide Companies by Tier (Tier 1, Tier 2, Tier 3), based on Inhaled Nitric Oxide Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inhaled Nitric Oxide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Inhaled Nitric Oxide Sales by Region (M L), 2021–2026
 Table 18. Global Inhaled Nitric Oxide Sales Market Share by Region (2021–2026)
 Table 19. Global Inhaled Nitric Oxide Sales by Region (M L), 2027–2032
 Table 20. Global Inhaled Nitric Oxide Sales Market Share by Region (2027–2032)
 Table 21. Global Inhaled Nitric Oxide Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Inhaled Nitric Oxide Revenue Market Share by Region (2021–2026)
 Table 23. Global Inhaled Nitric Oxide Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Inhaled Nitric Oxide Revenue Market Share by Region (2027–2032)
 Table 25. North America Inhaled Nitric Oxide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Inhaled Nitric Oxide Sales by Country (M L), 2021–2026
 Table 27. North America Inhaled Nitric Oxide Sales by Country (M L), 2027–2032
 Table 28. North America Inhaled Nitric Oxide Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Inhaled Nitric Oxide Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Inhaled Nitric Oxide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Inhaled Nitric Oxide Sales by Country (M L), 2021–2026
 Table 32. Europe Inhaled Nitric Oxide Sales by Country (M L), 2027–2032
 Table 33. Europe Inhaled Nitric Oxide Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Inhaled Nitric Oxide Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Inhaled Nitric Oxide Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Inhaled Nitric Oxide Sales by Region (M L), 2021–2026
 Table 37. Asia Pacific Inhaled Nitric Oxide Sales by Region (M L), 2027–2032
 Table 38. Asia Pacific Inhaled Nitric Oxide Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Inhaled Nitric Oxide Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Inhaled Nitric Oxide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Inhaled Nitric Oxide Sales by Country (M L), 2021–2026
 Table 42. Latin America Inhaled Nitric Oxide Sales by Country (M L), 2027–2032
 Table 43. Latin America Inhaled Nitric Oxide Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Inhaled Nitric Oxide Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Inhaled Nitric Oxide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Inhaled Nitric Oxide Sales by Country (M L), 2021–2026
 Table 47. Middle East and Africa Inhaled Nitric Oxide Sales by Country (M L), 2027–2032
 Table 48. Middle East and Africa Inhaled Nitric Oxide Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Inhaled Nitric Oxide Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Inhaled Nitric Oxide Sales (M L) by Type (2021–2026)
 Table 51. Global Inhaled Nitric Oxide Sales (M L) by Type (2027–2032)
 Table 52. Global Inhaled Nitric Oxide Sales Market Share by Type (2021–2026)
 Table 53. Global Inhaled Nitric Oxide Sales Market Share by Type (2027–2032)
 Table 54. Global Inhaled Nitric Oxide Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Inhaled Nitric Oxide Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Inhaled Nitric Oxide Revenue Market Share by Type (2021–2026)
 Table 57. Global Inhaled Nitric Oxide Revenue Market Share by Type (2027–2032)
 Table 58. Global Inhaled Nitric Oxide Price (US$/L) by Type (2021–2026)
 Table 59. Global Inhaled Nitric Oxide Price (US$/L) by Type (2027–2032)
 Table 60. Global Inhaled Nitric Oxide Sales (M L) by Application (2021–2026)
 Table 61. Global Inhaled Nitric Oxide Sales (M L) by Application (2027–2032)
 Table 62. Global Inhaled Nitric Oxide Sales Market Share by Application (2021–2026)
 Table 63. Global Inhaled Nitric Oxide Sales Market Share by Application (2027–2032)
 Table 64. Global Inhaled Nitric Oxide Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Inhaled Nitric Oxide Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Inhaled Nitric Oxide Revenue Market Share by Application (2021–2026)
 Table 67. Global Inhaled Nitric Oxide Revenue Market Share by Application (2027–2032)
 Table 68. Global Inhaled Nitric Oxide Price (US$/L) by Application (2021–2026)
 Table 69. Global Inhaled Nitric Oxide Price (US$/L) by Application (2027–2032)
 Table 70. Mallinckrodt (INOmax) Company Information
 Table 71. Mallinckrodt (INOmax) Description and Business Overview
 Table 72. Mallinckrodt (INOmax) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 73. Mallinckrodt (INOmax) Inhaled Nitric Oxide Product
 Table 74. Mallinckrodt (INOmax) Recent Developments/Updates
 Table 75. Linde (Noxivent) Company Information
 Table 76. Linde (Noxivent) Description and Business Overview
 Table 77. Linde (Noxivent) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 78. Linde (Noxivent) Inhaled Nitric Oxide Product
 Table 79. Linde (Noxivent) Recent Developments/Updates
 Table 80. Air Liquide (KINOX) Company Information
 Table 81. Air Liquide (KINOX) Description and Business Overview
 Table 82. Air Liquide (KINOX) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 83. Air Liquide (KINOX) Inhaled Nitric Oxide Product
 Table 84. Air Liquide (KINOX) Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Inhaled Nitric Oxide Distributors List
 Table 88. Inhaled Nitric Oxide Customers List
 Table 89. Inhaled Nitric Oxide Market Trends
 Table 90. Inhaled Nitric Oxide Market Drivers
 Table 91. Inhaled Nitric Oxide Market Challenges
 Table 92. Inhaled Nitric Oxide Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inhaled Nitric Oxide
 Figure 2. Global Inhaled Nitric Oxide Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Inhaled Nitric Oxide Market Share by Type: 2025 & 2032
 Figure 4. High Purity iNO Product Picture
 Figure 5. Standard Purity iNO Product Picture
 Figure 6. Global Inhaled Nitric Oxide Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Inhaled Nitric Oxide Market Share by Application: 2025 & 2032
 Figure 8. Infants PPHN
 Figure 9. ARDS
 Figure 10. Other Diseases
 Figure 11. Global Inhaled Nitric Oxide Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Inhaled Nitric Oxide Market Size (US$ Million), 2021–2032
 Figure 13. Global Inhaled Nitric Oxide Sales (M L), 2021–2032
 Figure 14. Global Inhaled Nitric Oxide Average Price (US$/L), 2021–2032
 Figure 15. Inhaled Nitric Oxide Report Years Considered
 Figure 16. Inhaled Nitric Oxide Sales Share by Manufacturers in 2025
 Figure 17. Global Inhaled Nitric Oxide Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Inhaled Nitric Oxide Players: Market Share by Revenue in Inhaled Nitric Oxide in 2025
 Figure 19. Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Inhaled Nitric Oxide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Inhaled Nitric Oxide Sales Market Share by Country (2021–2032)
 Figure 22. North America Inhaled Nitric Oxide Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Inhaled Nitric Oxide Sales Market Share by Country (2021–2032)
 Figure 26. Europe Inhaled Nitric Oxide Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Inhaled Nitric Oxide Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Inhaled Nitric Oxide Revenue Market Share by Region (2021–2032)
 Figure 34. China Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Inhaled Nitric Oxide Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Inhaled Nitric Oxide Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Inhaled Nitric Oxide Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Inhaled Nitric Oxide Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. U.A.E Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Inhaled Nitric Oxide by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Inhaled Nitric Oxide by Type (2021–2032)
 Figure 56. Global Inhaled Nitric Oxide Price (US$/L) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Inhaled Nitric Oxide by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Inhaled Nitric Oxide by Application (2021–2032)
 Figure 59. Global Inhaled Nitric Oxide Price (US$/L) by Application (2021–2032)
 Figure 60. Inhaled Nitric Oxide Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension